# C79E Authorized Red-Team Verification

## Status

```text
authorization / protocol / lock preflight: 24 / 24 PASS
field manifest and isolation red-team:      PASS
label-view provisioning red-team:           PASS
scientific-result red-team:                 17 / 17 PASS
blocking risks:                              0
```

Direct PI authorization bound protocol commit `ec4834c`, protocol SHA-256
`e350b7f0c4ee3dfcf6b4f5651c1c7a0e8beac72e478ffb6c1e98e12df814f587`,
field lock `35d0c65`, and analysis lock `7cebf2e` before the first seed-4
EEG load or job submission. The repaired implementation replayed against both
execution locks.

The field red-team replayed 1,458/1,458 engineering units, 1,296/1,296 primary
units, all checkpoint/state/sidecar and optimizer identities, 36/36 genealogy
cells, 36/36 cadence cells, and zero failed instrumentation units. Training
target rows, target-label reads, source-audit training rows, selector reads,
outcome-driven retention, and outcome-driven retry were all zero.

The label-view red-team replayed all eight locked construction/evaluation split
hashes, 2,235 construction rows, 2,373 evaluation rows, and zero overlap.
Target 4 remained engineering-only; the primary route contained neither an
oracle descriptor nor target-4 labels. Trial IDs and row order were keys and
dependence clusters only.

All ten scientific registry paths ran unconditionally once. There was no
`active_after_Holm` runtime selection, kernel or feature retuning, interim
branching, unregistered cross-seed pooling, p-value rescue, or scientific
repair. Six additive engineering repairs retained every failed attempt and
introduced zero scientific-registry changes, locked-implementation changes,
scientific-outcome reads, or outcome-dependent decisions.

The final claim audit permits only training-seed robustness/heterogeneity over
shared targets and trials. It rejects causal-representation, target-gauge,
deployability, target-population, universal-impossibility, and checkpoint
recommendation claims. The same-label oracle, seed 5, BNCI2014_004, C80, and
manuscript drafting remain closed.

